表紙
市場調查報告書
商品編碼
1071419

血管造影術設備:市場預測(2022年∼2027年)

Angiography Equipment Market - Forecasts from 2022 to 2027

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 131 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球血管造影術設備的市場規模在2020年估算為125億1,300萬美金,在預測期間內預計將以7.92%的年複合成長率擴大,2027年成為213億3,400萬美元。市場成長的主要因素有高患病率,以及全球癌症和心血管疾病發病率的增加等。

不斷增長的老年人口和世界肥胖人口導致需要血管造影的疾病激增。各個發達地區對產品批准的有利政府法規預計將推動全球市場增長。此外,對微創手術的偏好不斷變化,增加了對血管造影系統的需求。血管造影設備創新的進步預計將有助於市場增長,因為它們改善了醫療流程。然而,與採購和使用先進血管造影設備相關的高成本是全球市場增長的主要障礙。

本報告提供血管造影術設備的世界市場調查,提供市場規模和預測,市場促進因素及課題,市場趨勢,各市場區隔的市場分析,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 簡介

  • 市場定義
  • 市場區隔

第2章 調查手法

  • 調查資料
  • 假設

第3章 摘要整理

  • 調查的重點

第4章 市場動態

  • 推動市場要素
  • 阻礙市場要素
  • 波特的五力分析
    • 終端用戶談判力
    • 買方議價能力
    • 新加入廠商者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係
  • 產業的價值鏈分析

第5章 血管造影術設備市場分析:各技術

  • 簡介
  • X光血管造影術
  • 電腦斷層攝影血管造影術
  • 磁共振血管造影術

第6章 血管造影術設備市場分析:各治療

  • 簡介
  • 冠狀
  • 血管內
  • 神經血管

第7章 血管造影術設備市場分析:各用途

  • 簡介
  • 診斷
  • 治療

第8章 血管造影術設備市場分析:各終端用戶

  • 簡介
  • 醫院和診療所
  • 調查研究機關
  • 診斷中心

第9章 血管造影術設備市場分析:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 台灣
    • 泰國
    • 印尼
    • 其他

第10章 競爭環境與分析

  • 主要企業策略分析
  • 新興企業和市場收益性
  • 合併,收購,協定,及合作
  • 供應商競爭力矩陣

第11章 企業簡介

  • GE Healthcare
  • Siemens Healthcare
  • Philips Healthcare
  • Shimadzu Corporation
  • Canon Medical Systems Corporation
  • Carestream Health
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Cordis Corporation
  • AngioDynamics, Inc.
目錄
Product Code: KSI061611893

The angiography equipment market is evaluated at US$12.513 billion for the year 2020 and is projected to grow at a CAGR of 7.92% to reach the market size of US$21.334 billion by the year 2027.

The high prevalence, coupled with the increasing incidence of cancer and cardiovascular diseases around the world, is one of the major factors anticipated to drive the growth of the angiography equipment market during the forecast period. The rise in the geriatric population and an increase in the growing number of obese people around the world are leading to a surge in diseases that require angiography. Furthermore, favourable government regulations for the approval of the product in the various developed regions are also expected to fuel the growth of the global market. There is also a growing demand for angiography systems due to a shift in preference towards minimally invasive surgeries. Moreover, growing innovations in angiography equipment are improving the medical process and, hence, are anticipated to contribute to the market growth. However, high costs associated with the procurement and use of technologically advanced angiography equipment are a major factor likely to hamper the growth of the global market.

The recent outbreak of the novel coronavirus disease has a negative impact on the angiography equipment market. The pandemic shifted the major focus of the healthcare system towards COVID-19, and as part of the COVID-19 restrictions, a large number of procedures and surgeries had to be cancelled in many parts of the world, which led to a decline in the angiography equipment market in 2020. However, as the restrictions are being eased in most parts of the world, the market is anticipated to recover and continue at its normal pace from the year 2022 onwards.

The increasing prevalence of cardiovascular diseases

The world is witnessing a surge in the number of cases of cardiovascular diseases over the years, which is leading to an increased demand for angiography equipment and is projected to boost the market growth during the forecast period. A paper in the Journal of the American College of Cardiology stated in December 2020 that there were 270 million cases of cardiovascular diseases in 1990, which nearly doubled to 523 million in 2019. It also states that the number of people who died from cardiovascular disease increased from 12.1 million in 1990 to 18.6 million in 2019. The American Heart Association (AHA) predicts that 45% of the population of the United States will have at least one heart-related problem. It also estimates that the costs related to cardiovascular diseases will increase by 100% between 2016 and 2035. According to WHO, cardiovascular disease has the highest share in the list of leading causes of death. The organisation states that cardiovascular diseases caused 17.9 million deaths in 2019 around the world and represented 32% of all deaths worldwide. Premature deaths are also increasing with the growing prevalence of heart diseases, with 38% of all the 17 million premature deaths due to non-communicable diseases caused by CVDs in 2019. The growing trend of CVDs is projected to continue in the coming years as well and is anticipated to drive the market growth of angiography equipment.

Increase in innovation

The rising innovations in the market and the launch of advanced angiography equipment by the market players are widening the scope of angiography equipment and are anticipated to propel the growth of angiography equipment during the assessment period. The medical device company Kinepict Health has developed Kinepict Medical Imaging Tool (KMIT) software which uses the Digital Variance Angiography (DVA) technology and provides superior image quality compared to the conventionally-used technologies. The FDA has given clearance for it in March 2020, which has allowed it to be launched in the U.S. market. Furthermore, GE Healthcare has introduced the Allia IGS 7 angiography system at the Radiological Society of North America (RSNA) 2020 virtual meeting. The system makes use of artificial intelligence and allows better use of rotational angiography. Several other innovative products are being launched by various companies, leading to improvements in the angiography process and are anticipated to spur the growth of angiography equipment during the forecast period.

North America held a significant market share.

Geographically, the North American region is anticipated to hold a significant market share owing to the presence of a large number of market leaders, coupled with a high prevalence of cardiovascular diseases. Also, the presence of an advanced healthcare system allows a larger adoption of new and advanced angiography equipment. The Asia Pacific region is anticipated to witness substantial growth due to the rising number of cases of CVDs, coupled with increased investments in the healthcare sector in the region, which will lead to the availability of requisite healthcare facilities.

Market Segmentation

  • By Technology

X-Ray Angiography

Computed Tomography Angiography

Magnetic Resonance Angiography

  • By Procedure

Coronary

Endovascular

Neurovascular

  • By Application

Diagnostic

Therapeutic

  • By End-User

Hospitals and Clinics

Research Institutes

Diagnostic Centers

  • By Geography

North America

  • USA
  • Canada
  • Mexico

South America

  • Brazil
  • Argentina
  • Others

Europe

  • Germany
  • France
  • UK
  • Spain
  • Others

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Others

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of End-Users
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. Angiography Equipment Market Analysis, by Technology

  • 5.1. Introduction
  • 5.2. X-Ray Angiography
  • 5.3. Computed Tomography Angiography
  • 5.4. Magnetic Resonance Angiography

6. Angiography Equipment Market Analysis, by Procedure

  • 6.1. Introduction
  • 6.2. Coronary
  • 6.3. Endovascular
  • 6.4. Neurovascular

7. Angiography Equipment Market Analysis, by Application

  • 7.1. Introduction
  • 7.2. Diagnostic
  • 7.3. Therapeutic

8. Angiography Equipment Market Analysis, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals and Clinics
  • 8.3. Research Institutes
  • 8.4. Diagnostic Centers

9. Angiography Equipment Market Analysis, by Geography

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. UK
    • 9.4.4. Spain
    • 9.4.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Taiwan
    • 9.6.6. Thailand
    • 9.6.7. Indonesia
    • 9.6.8. Others

10. Competitive Environment and Analysis

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Emerging Players and Market Lucrativenessness
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Vendor Competitiveness Matrix

11. Company Profiles 

  • 11.1. GE Healthcare
  • 11.2. Siemens Healthcare
  • 11.3. Philips Healthcare
  • 11.4. Shimadzu Corporation
  • 11.5. Canon Medical Systems Corporation
  • 11.6. Carestream Health
  • 11.7. B. Braun Melsungen AG
  • 11.8. Boston Scientific Corporation
  • 11.9. Cordis Corporation
  • 11.10. AngioDynamics, Inc.